Ceftriaxone
Ceftriaxone is a laboratory-grade cephalosporin antibiotic. It is a broad-spectrum antibiotic effective against a wide range of gram-positive and gram-negative bacteria.
Lab products found in correlation
16 protocols using ceftriaxone
Urine Culture and Susceptibility Testing
Isolation and Antimicrobial Susceptibility of E. coli
The testing of susceptibility to ampicillin/sulbactam, ceftriaxone, cefotaxime, ceftazidime, cefepime, imipenem, meropenem, gentamicin, levofloxacin, and ciprofloxacin (all from Bio-Rad, USA) was performed by the disc-diffusion method using the Mueller-Hinton agar plates. The E. coli strain ATCC 25922 was used as a control. Current CLSI and EUCAST criteria were used for interpretation.
Antibiotic Susceptibility Testing Protocol
ESBL phenotypes were detected by double-disk synergy according to the method described by Jarlier et al. [10 (link)]. Disks of cefotaxime and ceftriaxone were placed 20 mm from an amoxicillin/clavulanate disk. Enhancement of the inhibition zone of the third-generation cephalosporin toward the amoxicillin/clavulanate disk indicated the possible presence of an ESBL. Escherichia coli ATCC 25922 was used as control.
Antibiotic Resistance Profiling of GNB Isolates
Strains with a narrow diameter zone of inhibition (ZOI) less than 15 mm were picked out to confirm the minimal inhibition concentration value using other complementary tests, namely the E-tests method (BioMérieux) and UMIC test (Biocentric Bandol, France) [29 (link)]. Furthermore, strains were considered to be multidrug-resistant (MDR) if bacteria were resistant to more than three different classes of antibiotics.
ESBL Screening in E. coli Isolates
Antimicrobial Susceptibility Testing Protocol
Antimicrobial Activity of A. fruticosa Fruits EO
Antibiotic Susceptibility of E. coli
In vitro susceptibility of E. coli isolates against antibiotics was performed using Kirby Bauer Agar Diffusion Method [19 (link)]. The antibiotics tested were penicillins (ampicillin, 10 μg; ticarcillin, 75 μg; piperacillin, 75 μg; oxacillin, 1 μg; and amoxicillin, 25 μg), cephalosporins (ceftriaxone, 30 μg; cefoxitin, 30 μg; cefalotin, 30 μg; cefepime, 30 μg; cefixime, 5 μg; cefotaxime, 30 μg; and ceftazidime, 10 μg), fluoroquinolones (ciprofloxacin, 5 μg and ofloxacin, 5 μg), glycopeptides (vancomycin, 5 μg), lincosamides (clindamycin, 2 μg), aminoglycosides (amikacin, 30 μg and gentamicin, 30 μg), and trimethoprim-sulfamethoxazole (25/23.75 μg) (BIORAD, France). Each assay was performed in triplicate. Antibacterial activity of antibiotics against E. coli isolates was evaluated by measuring the clear zone of growth inhibition (diameter of zone of inhibition) on agar surface around the discs as per clinical and laboratory standards institute (CLSI) guideline [20 ]. E. coli classified as susceptible, intermediate, and resistant strains according to the criteria of the CLSI [20 ]. Escherichia coli isolates were regarded as multidrug resistant (MDR) when they were resistant to one or more antibiotics in three or more classes of antimicrobials that the isolate is expected to be susceptible.
Antimicrobial Resistance Profiling of Diarrheagenic E. coli
Antibiotic Susceptibility Testing of Bacterial Isolates
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!